Presentations -
-
Impact of metabolic disease on treatment response in chronic hepatitis B patients with nucleos(t)ide analogues therapy: a multicenter REAL-B study International coauthorship International conference
Rui Huang, Dae Won Jun, Hidenori Toyoda, Yao-Chun Hsu, Huy Trinh, Akito Nozaki, Toru Ishikawa, Tsunamasa Watanabe, Haruki Uojima, Daniel Huang, Takashi Honda, Yasuhito Tanaka, Philip Vutien, Sebastián Marciano, Hiroshi Abe, Masaru Enomoto, Masanori Atsukawa, Hirokazu Takahashi, Kunihiko Tsuji, Ei Itobayashi, Koichi Takaguchi, Pei-Chien Tsai, Chia-Yen Dai, Jee-Fu Huang, Chung-Feng Huang, Ming-Lun Yeh, Eileen Yoon, Sung Eun Kim, Sang Bong Ahn, Gi-Ae Kim, JangHan Jung, Soung Won Jeong, Hyun Woo Oh, Cheng-Hao Tseng, Masatoshi Ishigami, Angela Chau, Tiffany Hsiao, Mayumi Maeda, Satoshi Yasuda, Makoto Chuma, Takanori Ito, Keigo Kawashima, Joann Kimiko Liu, Adrian Gadano, Ritsuzo Kozuka, Norio Itokawa, Kaori Inoue, Tomonori Senoh, Jie Li, Wan Long Chuang, Ramsey Cheung, Chao Wu, Ming-Lung Yu, Mindie Nguyen
AASLD2024 2024.11
-
Soluble Siglec-9 improves intestinal barrier function in a mouse model of metabolic-dysfunction associated steatohepatitis (MASH) International conference
Hisanori Muto,Fumitaka Mizuno, Shinya Yokoyama, Taku Tanaka, Kenta Yamamoto, Takanori Ito, yoji ishizu, Takashi Honda, Masatoshi Ishigami
AASLD2024 2024.11
-
Risk factors associated with decreased bone mineral density in patients with metabolic dysfunction-associated steatotic liver disease: a cross-sectional study at a health examination center International conference
Shinya Yokoyama,Takashi Honda, Kenta Yamamoto, Takanori Ito, Norihiro Imai, yoji ishizu, Kazuyuki Mizuno, Tetsuhito Kojima, Naoyoshi Kariya, Hiroki Kawashima
AASLD2024 2024.11
-
Fever after the administration of atezolizumab and bevacizumab predicts liver injury in patients with unresectable hepatocellular carcinoma: a prospective observational analysis using a multiplex bead-based immunoassay International conference
Takanori Ito,Takafumi Yamamoto, Kazuki Nishida, Yumiko Kobayashi, Kazuyuki Mizuno, Shinya Yokoyama, Norihiro Imai, yoji ishizu, Takashi Honda, Masatoshi Ishigami, Toshinari Koya, Sayori Nakashima, Takehito Naito, Satoshi Yasuda, Teiji Kuzuya, Hidenori Toyoda, Yuichi Ando, Sachiyo Yoshio, Hiroki Kawashima
AASLD2024 2024.11
-
Developing a Brief Evaluation Index to Diagnosis Metabolic Dysfunction-Associated Steatotic Liver Disease International coauthorship International conference
Xinyuan He, Zhiluo Yang, Takanori Ito, Hideyuki Hyogo, Masafumi Ono, Kentaro Oniki, Tetsuhito Kojima, Zhanpeng Yang, Sally Tran, Zixuan Xing, Yi Liu, Naoyoshi Kariya, Shinya Yokoyama, Ming-Hua Zheng, Junji Saruwatari, Hirokazu Takahashi, Takashi Honda, Mindie Nguyen, Fanpu JI
AASLD2024 2024.11
-
Pathological Significance of Intranuclear Lipid Droplets and Glycogenated Nuclei in Liver Biopsy International conference
Norihiro Imai, Yuki Ohsaki, Jinglei Cheng, Shinya Yokoyama, Kenta Yamamoto, Takanori Ito, yoji ishizu, Takashi Honda, Hiroaki Wake, Hiroki Kawashima, Jingjing ZHANG
AASLD2024 2024.11
-
Intestine-Specific Faf2 Depletion Ameliorates Metabolic Dysfunction-Associated Steatotic Liver Disease by Impairing Lipid Absorption International coauthorship International conference
Jingjing ZHANG, Norihiro Imai, Shinya Yokoyama, Kenta Yamamoto, Takanori Ito, yoji ishizu, Takashi Honda, Akiko Sugiyama, David Cohen, Hiroki Kawashima
AASLD2024 2024.11
-
Effect of age and development of liver and other organ cancers on HBs antigen loss in hepatitis B patients International conference
Takashi Honda, Kazuyuki Mizuno, Shinya Yokoyama, Kenta Yamamoto, Takanori Ito, Norihiro Imai, yoji ishizu, Yoshiki Murakami, Tetsuya Ishikawa, Hiroki Kawashima
AASLD2024 2024.11
-
Impact of Concurrent Fatty Liver (FL) and Chronic Hepatitis B (CHB) on Virologic (VR), Biochemical (BR), and Complete Response (CR) Among Patients Treated with Nucleos(t)ide Analogs (NA): A REAL-B Study International coauthorship International conference
Angela Chau, Dae Won Jun, Yao-Chun Hsu, Hidenori Toyoda, Ming-Lun Yeh, Tsunamasa Watanabe, Takashi Honda, Huy Trinh, Akito Nozaki, Haruki Uojima, Toru Ishikawa, Daniel Huang, Philip Vutien, Sebastián Marciano, Hiroshi Abe, Masanori Atsukawa, Masaru Enomoto, Hirokazu Takahashi, Kunihiko Tsuji, Koichi Takaguchi, Ei Itobayashi, Rui Huang, Pei-Chien Tsai, Chia-Yen Dai, Jee-Fu Huang, Chung-Feng Huang, Eileen Yoon, Sung Eun Kim, Sang Bong Ahn, Gi-Ae Kim, JangHan Jung, Soung Won Jeong, Hyun Woo Oh, Tiffany Hsiao, Mayumi Maeda, Cheng-Hao Tseng, Satoshi Yasuda, Masatoshi Ishigami, Makoto Chuma, Takanori Ito, Keigo Kawashima, Joanne Liu, Norio Itokawa, Ritsuzo Kozuka, Kaori Inoue, Tomonori Senoh, Wan Long Chuang, Adrian Gadano, Yasuhito Tanaka, Chao Wu, Ramsey Cheung, Jie Li, Ming-Lung Yu, Mindie Nguyen
AASLD2024 2024.11
-
The prevalence and natural history of diverse subtypes of indeterminate phase chronic hepatitis B: results of the international REAL-B cohort International coauthorship International conference
Ai-Thien Do, Ming-Lung Yu, Hidenori Toyoda, Seng Gee Lim, Ramsey Cheung, Man-Fung Yuen, Yasuhito Tanaka, Wan Long Chuang, Chao Wu, Maria Buti, Adrian Gadano, Ming-Lun Yeh, Chung-Feng Huang, Rui Huang, Jee-Fu Huang, Chia-Yen Dai, Mayumi Maeda, Kaori Inoue, Chul-Jin Lee, Cheng-Hao Tseng, Ana Barreira, Rex Wan-Hin Hui, Kwan-Lung Ko, Yoko Yoshimaru, Takanori Suzuki, Irina Sandra, Raluca Marin, Vy Nguyen, Yao-Chun Hsu, Huy Trinh, Jiayi Li, jianqing zhang, Eiichi Ogawa, Dong Hyun Lee, Takanori Ito, Tsunamasa Watanabe, Masaru Enomoto, Carmen Preda, Masanori Atsukawa, Sebastián Marciano, Son Do, Daniel Huang, Christopher Wong, Haruki Uojima, Hirokazu Takahashi, Htet Htet Toe Wai Khine, Takashi Honda, Norio Itokawa, Min Seok Go
AASLD2024 2024.11
-
Analysis of host factors to induce functional cure of HBV International conference
Takashi Honda, Yuichirou Harada, Shinya Yokoyama、Kenta Yamamoto、Takanori Ito、Norihiro Imai、Yoji Ishizu、Masahiko Kuroda, Hiroki Kawashima、Yoshiki Murakami
2024 Internatinal HBV Meeting 2024.9
-
B型肝炎症例におけるHBs抗原消失に対する年齢と肝癌及び他臓器癌発生の影響
本多 隆、水野和幸、武藤久哲、横山晋也、山本健太、伊藤隆徳、今井則博、石津洋二、石川哲也、川嶋啓揮
第110回消化器病学会総会 2024.5.9
-
慢性肝疾患患者における腸内細菌叢ネットワークと中心性指標の解明
山本健太、本多 隆、犬飼庸介、山本崇文、水野和幸、横山晋也、伊藤隆徳、今井則博、石津洋二、川嶋啓揮
第110回消化器病学会総会 2024.5.9
-
A HIGH FAT DIET MODULATES BILE ACID COMPOSITION AND GUT MICROBIOTA LEADING TO SEVERE CHOLANGITIS AND CIRRHOSIS IN A MURINE MODEL OF PBC International conference
Masahiro Umemura, Akira Honda, Maho Yamashita, Takeshi Chida, Hidenao Noritake, Kenta Yamamoto, Takashi Honda, Mayuko Ichimura-Shimizu, Koichi Tsuneyama, Patrick S.C. Leung, M Eric Gershwin, Kazuhito Kawata
AASLD2023 2023.11 AASLD2023
-
CHARACTERISTICS OF GUT MICROBIOTA ASSOCIATED WITH FUNCTIONAL CURE IN CHRONIC HEPATITIS B PATIENTS WITH HBEAG-NEGATIVE; POSSIBLE INHIBITION OF HEPATITIS B VIRUS BY BUTYRATE-PRODUCING BACTERIA International conference
Takashi Honda, Asako Murayama, Yosuke Inukai, Hisanori Muto, Shinya Yokoyama, Kenta Yamamoto, Takanori Ito, Norihiro Imai, Yoji Ishizu, Masatoshi Ishigami, Sachiyo Yoshio, Tetsuya Ishikawa, Hiroki Kawashima, Takanobu Kato
AASLD2023 2023.11
-
PREVALENCE OF INTRANUCLEAR LIPID DROPLETS IN NONALCOHOLIC FATTY LIVER DISEASE International conference
Norihiro Imai, Yuki Ohsaki, Jinglei Cheng, Jingjing Zhang, Fumitaka Mizuno, Taku Tanaka, Shinya Yokoyama, Kenta Yamamoto, Takanori Ito, Yoji Ishizu, Takashi Honda, Masatoshi Ishigami, Hiroaki Wake, Hiroki Kawashima
AASLD2023 2023.11
-
INTESTINAL MICROBIOME ASSOCIATED WITH EFFICACY OF ATEZOLIZUMAB AND BEVACIZUMAB THERAPY FOR HEPATOCELLULAR CARCINOMA International conference
Yosuke Inukai, Kenta Yamamoto, Takashi Honda, Shinya Yokoyama, Takanori Ito, Norihiro Imai, Yoji Ishizu, Masanao Nakamura, Masatoshi Ishigami,Hiroki Kawashima
AASLD2023 2023.11 AASLD2023
-
CLINICAL FEATURES AND OUTCOME OF LIVER INJURY INDUCED BY IMMUNE CHECKPOINT INHIBITORS IN PATIENTS WITH ADVANCED MALIGNANCIES International conference
Takanori Ito, Takafumi Yamamoto, Kazuyuki Mizuno, Shinya Yokoyama, Norihiro Imai, Kenta Yamamoto, Yoji Ishizu, Takashi Honda, Satoshi Yasuda, Hidenori Toyoda, Masatoshi Ishigami, Hiroki Kawashima
AASLD2023 2023.11 AASLD2023
-
CLINICAL OUTCOMES OF POROUS GLASS MEMBRANE PUMPING EMULSIFICATION DEVICE IN TRANSARTERIAL CHEMOEMBOLIZATION FOR HEPATOCELLULAR CARCINOMA International conference
Fumitaka Mizuno, Norihiro Imai, Shinya Yokoyama, Kenta Yamamoto, Takanori Ito, Yoji Ishizu, Takashi Honda, Masatoshi Ishigami, Hiroki Kawashima
AASLD2023 2023.11 AASLD2023
-
CROSS-SECTIONAL STUDY IN GENERAL POPULATION FOR THE PREVALENCE OF NONALCOHOLIC FATTY LIVER DISEASE, DISTRIBUTION OF FIBROSIS STAGE USING VIBRATION-CONTROLLED TRANSIENT ELASTOGRAPHY, AND DETERMINING THE BEST CUT OFF VALUE OF FIB-4 INDEX. International conference
Yuji Ogawa, Wataru Tomeno, Michihiro Iwaki, Takashi Kobayashi, Asako Nogami, Takaomi Kessoku, Kazuo Notsumata, Hirotoshi Fujikawa, Kento Imajo, Masaru Baba, Miwa Kawanaka, Hideyuki Hyogo, Taku Hakamada, Takashi Honda, Miwa Tatsuta, Takato Ueno, Shigeru Mikami, Yasushi Imamura, Ken Furuya, Noriaki Manabe, Tomoari Kamada, Masato Yoneda, Takumi Kawaguchi, Satoru Saito, Atsushi Nakajima
AASLD2023 2023.11 AASLD2023
-
B型慢性肝炎患者におけるエンテカビル(ETV)からテノホビル・ アラフェナミド(TAF)への切り替えによるHBs抗原減少効果の検討 －混合効果モデルを用いたトレンドシフト解析－
本多 隆、熊田 卓、川嶋啓揮
第45回日本肝臓学会西部会 2023.12.7
-
B型慢性肝炎患者における免疫要素を加味した機能的治癒 (Functional Cure)予測因子としてのコアI97L変異の可能性
本多 隆、石上雅敏、石川哲也
第59回日本肝臓学会総会 2023.6.15
-
Chemokine changes before and after induction of CoreI97L mutation by IFN-based therapy in patients with chronic hepatitis B
Takashi Honda, Masatoshi Ishigami, Hiroki Kawashima
2023.11.3
-
ネットワーク解析を用いた線維化マーカーと腸内細菌叢の関係性の解明
山本 健太， 本多 隆，石上 雅敏
第109回消化器病学会総会 2023.4.6
-
HBe 抗原陰性 B 型肝炎患者における Functional cure 症例の腸内細菌の特徴
本多 隆、石上雅敏、川嶋啓揮
第109回消化器病学会総会 2023.4.8
-
USEFULNESS OF MUTATIONS INDUCED IN THE CORE REGION BY INTERFERON-BASED THERAPY International conference
Takashi Honda, Masatoshi Ishigami, Asuka Kato, Shinya Yokoyama, Kenta Yamamoto, Takanori Ito, Norihiro Imai, Yoji Ishizu, Satoshi Yasuda, Hidenori Toyoda, Takashi Kumada, Tetsuya Ishikawa, Hiroki Kawashima
2022.11.4
-
PREVALENCE OF NONALCOHOLIC FATTY LIVER DISEASE AND DISTRIBUTION OF EACH FIBROSIS STAGE USING VIBRATION-CONTROLLED TRANSIENT ELASTOGRAPHY International conference
Yuji Ogawa, Asako Nogami, Takaomi Kessoku, Kazuo Notsumata, Hirotoshi Fujikawa, Wataru Tomeno, Kento Imajo, Masaru Baba, Miwa Kawanaka, Hideyuki Hyogo, Taku Hakamada, Takashi Honda, Miwa Tatsuta, Takato Ueno, Shigeru Mikami, Yasushi Imamura, Ken Furuya, Masato Yoneda, Takumi Kawaguchi, Satoru Saito, Prof. Atsushi Nakajima, Tatsuji Komatsu
AASLD2022 2022.11 AASLD2022
-
CLINICAL COURSE AND PROGNOSIS OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH HEMOPHILIA International conference
Norihiro Imai, Masatoshi Ishigami, Noritaka Matsuda, Shinya Yokoyama, Kenta Yamamoto, Takanori Ito, Yoji Ishizu, Takashi Honda, Hiroki Kawashima
AASLD2022 2022.11
-
ANOREXIA IS ASSOCIATED WITH THE PRESENCE OF SARCOPENIA IN PATIENTS WITH CIRRHOSIS International conference
Yoji Ishizu, Shinya Yokoyama, Kenta Yamamoto, Takanori Ito, Norihiro Imai, Takashi Honda Honda, Masatoshi Ishigami and Hiroki Kawashima
AASLD2022 2022.11
-
B型肝炎のFunctional cureを目指したインターフェロン治療の効果とコア領域の変異測定の有用性
本多隆, 豊田秀徳, 安田諭, 横山晋也, 山本健太, 伊藤隆徳, 今井則博, 石津洋二, 石川哲也, 石上雅敏
JDDW2022 2022.10.28
-
B型慢性肝炎患者における機能的治癒(Functional Cure)症例の特徴とコアI97L変異の関係
本多隆, 加藤孝宣, 石上雅敏
第58回日本肝臓学会総会 2022.6.2 日本肝臓学会
-
B型慢性肝炎患者における機能的治癒（Functional Cure）予測因子としてのコアI97L変異の可能性
本多隆, 加藤孝宜, 石上雅敏
第108回消化器病学会総会 2022.4.21 消化器病学会
-
Possible prediction of functional cure by HBV core mutations in patients with chronic hepatitis B
Takashi Honda, Masatoshi Ishigami, Takafumi Yamamoto, Yosuke Inukai, Yoshiaki Sugiyama, Naoki Yoshioka, Kazuhiro Mizuno, Hisanori Muto, Shinya Yokoyama, Taku Tanaka, Kenta Yamamoto, Takanori Ito, Norihiro Imai, Yoji Ishizu, Mitsuhiro Fujishiro
2021.11.4
-
多孔質ガラス膜-薬液混合コネクタを用いた肝動脈化学塞栓術の治療成績
今井則博、山本 健太、伊藤 隆徳、石津 洋二、本多 隆、石上 正敏、藤城 光弘
JDDW2021 2021.11.4 肝臓学会
-
Rifaximin投与患者におけるアンモニア測定の意義
石津 洋二、石上 正敏、山本 崇文、犬飼 庸介、杉山 由晃、吉岡 直輝、水野 和幸、武藤 久哲、横山 晋也、山本 健太、伊藤 隆徳、今井則博、本多 隆、藤城 光弘
JDDW2021 2021.11.4 肝臓学会
-
慢性肝疾患患者における筋肉量,血清分岐鎖アミノ酸濃度,細菌叢の相関に関する検討
山本 健太、本多 隆、藤城 光弘
JDDW2021 2021.11.4 肝臓学会
-
Usefulness of core I97L in predicting the efficacy of nucleos(t)ide analogue therapy in patients with hepatitis B International conference
Takashi Honda, Masatoshi Ishigami, Kenta Yamamoto, Takanori Ito, Norihiro Imai, Yoji Ishizu, Mitsuhiro Fujishiro
AASLD2021 2021.11
-
Differences in the intestinal microbiome associated with diarrhea during lenvatinib treatment for hepatocellular carcinoma International conference
Yosuke Inukai, Kenta Yamamoto, Takashi Honda, Takanori Ito, Norihiro Imai, Yoji Ishizu, Masanao Nakamura, Hiroki Kawashima, Masatoshi Ishigami, Mitsuhiro Fujishiro
AASLD2021 2021.11
-
The impact of hepatitis C virus eradication on hepatocarcinogenesis in haemophiliacs International conference
Inukai Yosuke, Imai Norihiro, Yamamoto Kenta, Ito Takanori, Ishizu Yoji, Honda Takashi, Ishigami Masatoshi
EASL2021 2021.7
-
肝硬変による入院イベントと腸内細菌叢の関連性
山本健太、本多 隆、山本 崇文、犬飼 庸介、杉山 由晃、吉岡 直輝、水野 和幸、武藤 久哲、横山 晋也、伊藤 隆徳、今井則博、石津 洋二、石上 正敏、藤城 光弘
第57回日本肝臓学会総会 2021.6.18 肝臓学会
-
核酸アナログ治療中止可能予測因子とHBVコア変異の関係
本多 隆、石上 雅敏、山本 崇文、犬飼 庸介、杉山 由晃、吉岡 直輝、水野 和幸、武藤 久哲、横山 晋也、山本 健太、伊藤 隆徳、今井則博、石津 洋二、石川 哲也、藤城 光弘
第57回日本肝臓学会総会 2021.6.18 肝臓学会
-
核酸アナログ治療中止可能予測因子とHBVコア変異の関係
本多 隆, 石上 雅敏, 山本 崇文, 犬飼 庸介, 杉山 由晃, 吉岡 直輝, 水野 和幸, 武藤 久哲, 横山 晋也, 山本 健太, 伊藤 隆徳, 今井則博, 石津 洋二, 石川 哲也, 藤城 光弘
第57回日本肝臓学会総会 2021.6.18 肝臓学会
-
Functional cureに関与するコア領域のアミノ酸変異がHBVライフサイクルに与える影響の解析
加藤 孝宣、山田 典栄、本多 隆
第57回日本肝臓学会総会 2021.6.1
-
The impact of hepatitis C virus eradication on hepatocarcinogenesis in haemophiliacs International conference
Yosuke Inukai, Norihiro Imai, Kenta Yamamoto, Takanori Ito, Yoji Ishizu, Takashi Honda, Masatoshi Ishigami,Mitsuhiro Fujishiro
2021.6
-
慢性肝疾患患者における生活習慣・排便状況調査と腸内細菌叢に与える影響
山本 健太、本多 隆、藤城 光弘
第107回消化器病学会総会 2021.4.17 消化器病学会
-
慢性肝疾患患者における生活習慣・排便状況調査と腸内細菌叢に与える影響
山本 健太, 本多 隆, 藤城 光弘
第107回消化器病学会総会 2021.4.17 消化器病学会
-
B型慢性肝炎におけるFunctional cureに関連するHBVコア変異
本多 隆、加藤 孝宣、藤城 光弘
第107回消化器病学会総会 2021.4.15 消化器病学会
-
肝硬変患者に対する分岐アミノ酸投与による腸内細菌叢の違い
犬飼庸介、本多 隆、山本健太、山本崇文、杉山由晃、吉岡直輝、水野和幸、武藤久哲、横山晋也、田中 卓、伊藤隆徳、石津洋二、葛谷貞二、石上正敏、藤城光弘
JDDW2020 2020.11
-
非肝癌症例と肝発癌症例の違いに関与する腸内細菌の検討
本多 隆, 石上 雅敏, 山本 崇文, 犬飼 庸介, 杉山 由晃, 吉岡 直輝, 水野 和幸, 武藤 久哲, 横山 晋也, 田中 卓, 山本 健太, 伊藤 隆徳, 石津 洋二, 葛谷 貞二, 石川 哲也, 藤城 光弘
JDDW2020 2020.11
-
SAFETY AND EFFICACY OF PERCUTANEOUS RADIOFREQUENCY ABLATION FOR HEPATOCELLULAR CARCINOMA PATIENTS WITH HEMOPHILIA International conference
Yamamoto Takafumi, Ishigami Masatoshi, Yamamoto Kenta, Ito Takanori, Imai Norihiro, Lshizu Yoji, Honda Takashi, Fujishiro Mitsuhiro
AASLD2020 2020.11
-
IMPROVEMENT OF LIVER FUNCTIONAL RESERVE AFTER SVR IN HCV-PATIENTS WITH COMPENSATED, SEVERE FIBROSIS BY IFN-FREE, DAA COMBINATION TREATMENT-IMPACT OF PRETREATMENT SERUM AFP LEVELS International conference
Ishigami Masatoshi, Honda Takashi, Ishizu Yoji, Imai Norihiro, Ito Takanori, Yamamoto Kenta, Fujishiro Mitsuhiro
AASLD2020 2020.11
-
GUT MICROBIOTA ASSOCIATED WITH THE DIFFERENCE BETWEEN PATIENTS WITH AND WITHOUT HEPATOCELLULAR CARCINOMA IN CHRONIC LIVER DISEASE International conference
Honda Takashi, Ishigami Masatoshi, Yamamoto Kenta, Ito Takanori, Imai Norihiro, Ishizu Yoji, Fujishiro Mitsuhiro
AASLD2020 2020.11
-
AMINO ACID POLYMORPHISM IN HEPATITIS B VIRUS ASSOCIATED WITH NATURAL CLEARANCE OF HBV DNA AND HBsAg International conference
Honda Takashi, Yamada None, Murayama Asako, Kato Asuka, Ito Takanori, Ishizu Yoji, Kuzuya Teiji, Ishigami Masatoshi, Murakami Yoshiki, Ishikawa Tetsuya, Fujishiro Mitsuhiro, Kato Takanobu
AASLD2020 2020.11
-
B型肝炎患者におけるFunctional cureと腸内細菌の関係
本多 隆、石上雅敏、藤城光弘
第106回消化器病学会総会 2020.8.11
-
慢性肝疾患患者における腸内細菌叢のPredicted Functional Dysbiosisに影響を与える因子についての検討
山本健太、本多 隆、石上雅敏
第56回日本肝臓学会総会 2020.5.22
-
B型肝炎症例におけるテノホビル ジソプロキシルフマル酸塩への切替えによるHBV DNA、HBs抗原、 ALT値の変化に関する検討
本多 隆, 石上雅敏, 山本崇文, 犬飼庸介, 吉岡直輝, 水野和幸, 武藤久哲, 横山晋也, 田中卓, 山本健太, 伊藤隆徳, 石津洋二, 葛谷貞二, 石川哲也, 藤城光弘
第56回日本肝臓学会総会 2020.5.22 第56回日本肝臓学会総会
-
ASSOCIATION BETWEEN FASTING BREATH HYDROGEN LEVELS AND PANCREATIC EXOCRINE INEFFICIENCY International conference
Uetsuki Kota, Kawashima Hiroki, Ohno Eizaburo, Ishikawa Takuya, Nakamura Masanao, Furukawa Kazuhiro, Ishigami Masatoshi, Honda Takashi, Fujishiro Mitsuhiro
AGA2020 2020.5
-
EXAMINATION OF NEW PREDICTIVE FACTORS USING ENDOSCOPY AND SERUM CYTOKINE LEVELS FOR USTEKINUMAB IN CROHN'S DISEASE International conference
Murate Kentaro, Maeda Keiko, Nakamura Masanao, Sugiyama Daisuke, Wada Hirotaka, Yamamura Takeshi, Sawada Tsunaki, Mizutani Yasuyuki, Ishikawa Takuya, Furukawa Kazuhiro, Ohno Eizaburo, Honda Takashi, Kawashima Hiroki, Ishigami Masatoshi, Nishikawa Hiriyoshi, Fujishiro Mitsuhiro
AGA2020 2020.5
-
QUANTITATIVE EVALUATION OF TREATMENT EFFECT USING SHEAR WAVE ELASTOGRAPHY AND SHEAR WAVE DISPERSION IN AUTOIMMUNE PANCREATITIS International conference
Suzuki Hirotaka, Kawashima Hiroki, Ohno Eizaburo, Ishikawa Takuya, Nakamura Masanao, Furukawa Kazuhiro, Ishigami Masatoshi, Honda Takashi, Fujishiro Mitsuhiro
AGA2020 2020.5
-
C型肝癌症例に関連する腸内細菌の検討
JDDW2019 2019.11.21
-
UTILITY OF THE ALBUMIN-BILIRUBIN SCORE FOR PREDICTING PROGNOSIS IN JAPANESE PATIENTS WITH PRIMARY BILIARY CHOLANGITIS: AN ANALYSIS USING TIME-DEPENDENT RECEIVER OPERATING CHARACTERISTICS International conference
Ito Takanori, Ishigami Masatoshi, Ishizu Yoji, Kuzuya Teiji, Honda Takashi, Yasuda Satoshi, Toyoda Hidenori, Kumada Takashi, Fujishiro Mitsuhiro
AASLD2019 2019.10
-
CHANGES OF MICROBIOTA AFTER HEPATITIS C VIRUS ERADICATION International conference
Honda Takashi, Ishigami Masatoshi, Yamamoto Kenta, Ito Takanori, Ishizu Yoji, Kuzuya Teiji, Fujishiro Mitsuhiro
AASLD2019 2019.10
-
NON-INVASIVE SCREENING FOR DETECTING ESOPHAGOGASTRIC VARICES IN CHILDREN WITH BILIARY ATRESIA International conference
Yokoyama Shinya, Ishigami Masatoshi, Honda Takashi, Kuzuya Teiji, Ishizu Yoji, Ito Takanori, Shirota Chiyoe, Uchida Hiroo, Fujishiro Mitsuhiro
AASLD2019 2019.10
-
INDICATION FOR HCC TREATMENT IN RECENT ERA-PROPOSAL OF THE NEW PRIORITY FOR LIVER TRANSPLANTATION IN PATIENTS WITH HCC International conference
Ishigami Masatoshi, Honda Takashi, Kuzuya Teiji, Ishizu Yoji, Ito Takanori, Fujishiro Mitsuhiro
AASLD2019 2019.10
-
The relationship between portal hypertension and the microbiome International conference
Yamamoto K., Honda T., Hattori S., Pu L. Zorron Cheng Tao, Ito T., Yamamura T., Ishizu Y., Kuzuya T., Ishigami M., Fujishiro M.
AGW2019 2019.9
-
Specific members of gut microbiota predict mucosal healing in Crohn's disease International conference
Hattori S., Nakamura M., Yamamura T., Maeda K., Sawada T., Mizutani Y., Yamamoto K., Pu L. Zorron Cheng Tao, Honda T., Ishikawa T., Furukawa K., Ohno E., Miyahara R., Kawashima H., Fujishiro M.
AGW2019 2019.9
-
Microbiota profile is markedly different for early and invasive colorectal cancer and is consistent throughout the colon International coauthorship International conference
Pu L. Zorron Cheng Tao, Yamamoto K., Honda T., Hattori S., Nakamura M., Yamamura T., Burt A., Hirooka Y., Singh R., Fujishiro M.
AGW2019 2019.9
-
核酸アナログ治療症例におけるHBVcore変異とウイルス量、HBsAg、HBcrAgの関係
本多 隆、石上雅敏、藤城光弘
肝臓学会総会 2019.5.30
-
慢性肝疾患例における肝発癌症例に関連する腸内細菌叢の検討
本多 隆、石上雅敏、廣岡芳樹
消化器病学会総会 2019.5.9
-
The optimal cut-off points of FIB-4 index for predicting the incidences of HCC and extra-hepatic malignancies in biopsyproven Japanese NAFLD patients International conference
Ito Takanori, Ishigami Masatoshi, Ishizu Yoji, Kuzuya Teiji, Honda Takashi, Fujishiro Mitsuhiro
EASL2019 2019.4
-
The early clinical response at 2 weeks of lenvatinib therapy for patients with advanced HCC International conference
Kuzuya Teiji, Ishigami Masatoshi, Ito Takanori, Ishizu Yoji, Honda Takashi, Fujishiro Mitsuhiro
EASL2019 2019.4
-
Serum Zinc levels as a prognostic factor for extra-hepatic carcinogenesis in Japanese patients with non-alcoholic liver disease International conference
Ito Takanori, Ishigami Masatoshi, Ishizu Yoji, Kuzuya Teiji, Honda Takashi, Fujishiro Mitsuhiro
EASL2019 2019.4
-
Association between gut microbiota and hepatocellular carcinoma in patients with chronic liver disease International conference
Honda Takashi, Ishigami Masatoshi, Yamamoto Kenta, Ito Takanori, Ishizu Yoji, Kuzuya Teiji, Fujishiro Mitsuhiro
EASL2019 2019.4
-
Association between Core Mutations Induced By Interferon Therapy and Annual Decline Rate of Hbvdna in Chronic Hepatitis B Patients International conference
Takashi Honda, Masatoshi Ishigami, Takanori Ito, Yoji Ishizu, Teiji Kuzuya and Yoshiki Hirooka,
AASLD2018 2018.11.12
-
自然経過及び治療症例におけるHBVcoreI97L変異とウイルス量，HBsAg減少の関係
本多 隆、石上雅敏、廣岡芳樹
JDDW2018 2018.11.12
-
C型肝炎ウイルス駆除による腸内細菌叢への影響
本多 隆、石上雅敏、廣岡芳樹
JDDW2018 2018.11.1
-
Novel Candidate Drugs That Target Cccdna of HBV International conference
Murakami Yoshiki, Hayakawa Michiyo, Itami-Matsumoto Saari, Ando Mari, Yata Yutaka, Enomoto Masaru, Tamori Akihiro, Kawada Norifumi, Honda Takashi, Yano Yoshihiko, Iwadate Mitsuo, Umeyama Hideaki
AASLD2018 2018.10
-
Late Relapse and Molecular Analysis of Hepatitis C Virus in Patients with Sustained Virological Response By All Oral Direct Acting Antivirals Therapy International conference
Hayashi Kazuhiko, Ishizu Yoji, Kuzuya Teiji, Honda Takashi, Ishigami Masatoshi, Shimizu Yuko, Tachi Kousuke, Goto Hidemi
AASLD2018 2018.10
-
Interferon-Free Antiviral Therapy Rapidly Improves Thrombocytopenia in Patients with Advanced Chronic Hepatitis C International conference
Ishizu Yoji, Ishigami Masatoshi, Ito Takanori, Kuzuya Teiji, Honda Takashi, Hirooka Yoshiki
AASLD2018 2018.10
-
Comparison of Gut Microbiota and Predicted Functional Metagenome in Hepatitis C Patients with and without Advanced Fibrosis Categorized By FIB4-Index International conference
Yamamoto Kenta, Ishigami Masatoshi, Ito Takanori, Ishizu Yoji, Kuzuya Teiji, Honda Takashi, Hirooka Yoshiki
AASLD2018 2018.10
-
Association between Core Mutations Induced By Interferon Therapy and Annual Decline Rate of Hbvdna in Chronic Hepatitis B Patients International conference
Honda Takashi, Ishigami Masatoshi, Ito Takanori, Ishizu Yoji, Kuzuya Teiji, Hirooka Yoshiki
AASLD2018 2018.10
-
インターフェロン治療によるHBV core I97L変異の 誘導とHBV DNA及びHBsAg減少率に関する検討
本多 隆、石上雅敏、後藤秀実
第54回日本肝臓学会総会 2018.6.14
-
C型肝炎ウイルスの肝病態による腸内細菌叢の違いと駆除後の肝癌発症との関連
本多 隆、石上雅敏、廣岡芳樹
肝臓学会総会 2018.6.14
-
C型肝炎による肝発癌に関連する腸内細菌叢の検討
本多 隆、廣岡芳樹、後藤秀実
消化器病学会総会 2018.4.20
-
Naturally occurring drug resitance substitutions in the NS5A and NS5B regions in Hepatitis C virus genotype 2 and response to sofosbuvir plus ribavirin therapy International conference
Hayashi K., Ishigami M., Ishizu Y., Kazuya T., Honda T., Hirooka Y., Goto H.
EASL2018 2018.4
-
Utility and limitation of non-invasive fibrosis markers for predicting the prognosis in biopsy-proven Japanese NAFLD patients International conference
Ito T., Ishigami M., Ishizu Y., Kazuya T., Honda T., Hayashi K., Ishikawa T., Hirooka Y., Goto H.
EASL2018 2018.4
-
Secreted ectodomain of SIGLEC-9 and MCP-1 ameliorate acute liver failure in rats by altering bone marrow macrophage polarity International conference
Ito T., Ishigami M., Yamamoto A., Ishizu Y., Kazuya T., Honda T., Hayashi K., Ishikawa T., Hirooka Y., Goto H.
EASL2018 2018.4
-
Prognostic factors related to post-progression survival in advanced hepatocellular carcinoma patients treated with sorafenib not eligible for second-line regorafenib treatment Teiji Kuzuya* 1, Masatoshi Ishigami1, Takanori Ito1, Yoji Ishizu1"
Kuzuya T, Ishigami M, Ito T, Ishizu Y, Honda T, Hirooka Y
ILCA2018 2018
-
Association between microbiome and hepatitis C virus-infected patients with hepatocellular carcinoma International conference
Honda T, Ishigami M, Yamamoto K, Ito T, Ishizu Y, Kuzuya T, Hirooka Y
ILCA2018 2018
-
Daclatasvir and asunaprevir treatment in patients with severe liver fibrosis by hepatitis C virus genotype 1b infection: Real-world data International conference
Ishigami Masatoshi, Hayashi Kazuhiko, Honda Takashi, Kuzuya Teiji, Ishizu Yoji, Ishikawa Tetsuya, Nakano Isao, Urano Fumihiro, Kumada Takashi, Yoshioka Kentaro, Goto Hidemi, Hirooka Yoshiki
APASL 2017.11
-
B型慢性肝炎におけるインターフェロン治療効果とcoreI97L変異によるその後の肝炎沈静化の予測
本多隆、石上雅敏、後藤秀実
JDDW2017 2017.10.12
-
非B非C肝癌における肝発癌に関連する腸内細菌叢の検討
本多隆
JDDW2017 2017.10.12
-
Core I97LとP79Qの変異はB型慢性肝炎患者において持続HBVDNA低値とHBs抗原消失に関与する
本多 隆、石上雅敏、後藤秀実
第53回日本肝臓学会総会 2017.6.8
-
The Impact of Hepatitis B Virus Infection on Sustained Virologic Response and HBV Reactivation in Patients with Chronic Hepatitis C who Treated by all-Oral Direct-Acting Antivirals Regimens International conference
Hayashi K, Ishigami M, Ishizu Y, Kuzuya T, Honda T, Hirooka Y, Goto H
DDW2017 2017
-
The Association Between Amino Acid Substitutions in the NS5A Region of Hepatitis C Virus and Development of Hepatocellular Carcinoma After Sustained Virological Response International conference
Yashuda S, Ishigami M, Ishizu Y, Kuzuya T, Honda T, Hayashi K, Hirooka Y, Goto H"
DDW2017 2017
-
B型慢性肝炎におけるインターフェロン治療効果とCoreI97L変異による治療効果の予測
本多隆
JDDW2016 2016.11.2
-
Relation between core mutations and HBVDNA, HBsAg decreasing rate in the patients with chronic hepatitis B International conference
Takashi Honda
APDDW2016 2016.11.2
-
Revisiting the prognosis after liver transplantation in HCV-positive patients-focus on HCV-unrelated complications International conference
Ishigami Masatoshi, Hayashi Kazuhiko, Honda Takashi, Kuzuya Teiji, Ishizu Yoji, Hirooka Yoshiki, Goto Hidemi
APASL2016 2016.11
-
Treatment for elderly patients with hepatitis C Invited International conference
Takashi Honda, Masatoshi Ishigami, Kazuhiko Hayashi, Hidemi Goto
3rd International Monothematic Conference on Viral Hepatitis C 2016.9.29
-
コリン欠乏高脂肪食によるNASHマウスモデルにおける分岐鎖アミノ酸投与による糖質、アミノ酸代謝の変化
本多 隆、石上雅敏、山本健太、安藤祐資、安田 諭、伊藤隆徳、野村 彩、加藤幸一郎、新家卓郎、石津洋二、葛谷貞二、林 和彦、廣岡芳樹、石川哲也、中野功、後藤秀実
第3回肝臓と糖尿病代謝研究会 2016.7.16
-
Efficacy of dual oral therapy with asunaprevir and daclatasvir for elderly patients with hepatitis C International conference
Honda T, Ishigami M , Ishizu Y, Kuzuya T, Hayashi K, Hirooka Y, Goto H
HCVmeeting2016 2016.7.7
-
Core I97L mutation is associated with persistent low HBV DNA and HBsAg clearance in patients with chronic hepatitis B International conference
Takashi Honda, Masatoshi Ishigami, Yoji Ishizu, Teiji Kuzuya, Kazuhiko Hayashi, Yoshiki Hirooka, Hidemi Goto
DDW2016 2016.5.24
-
B型慢性肝炎におけるcoreI97L変異とHBV DNA減少及びHBs抗原の消失に関する検討
本多 隆、石上雅敏、後藤秀実
第52回日本肝臓学会総会 2016.5.19
-
HBs抗原消失がみられI97L変異の長期観察ができた症例の検討
本多隆
第101回日本消化器病学会総会 2016.4.23
-
B型慢性肝炎におけるcoreI97L変異による持続HBV DNA低値ALT正常及びHBs抗原消失の予測
本多 隆、石上雅敏、後藤秀実
第41回日本肝臓学会西部会 2015.12.4
-
高齢者C型慢性肝炎におけるDaclatasvir /Asunaprevir併用療法の早期反応と治療効果
本多 隆、石上雅敏、安藤祐資、安田 諭、伊藤隆徳、川口 彩、加藤幸一郎、新家卓郎、今井則博、阿知波宏一、石津洋二、葛谷貞二、林 和彦、石川哲也、中野 功、後藤秀実
第41回日本肝臓学会西部会 2015.12.4
-
Early response and efficacy of dual oral therapy with asunaprevir and daclatasvir for elderly patients with hepatitis C International conference
Takashi Honda, Masatoshi Ishigami, Yoji Ishizu, Teiji Kuzuya, Kazuhiko Hayashi, Yoshiki Hirooka, Hidemi Goto
AASLD2015 2015.11.15
-
B型慢性肝炎におけるHBVDNA及びHBs抗原減少に関与するウイルス遺伝子変異の検討
本多 隆、石上雅敏、後藤秀実
JDDW2015 2015.10.8
-
DSS colitis has tumorinogenesis and fibrogenesis in choline-deficiency and high-fat diet induced NASH mouse model International conference
Achiwa Koichi, Ishigami Masatoshi, Ishizu Yoji, Kuzuya Teiji, Honda Takashi, Hayashi Kazuhiko, Hirooka Yoshiki, Goto Hidemi
AASLD2015 2015.10
-
A comparison of direct sequencing and PCR-invader assay for the detection of NS5A Y93H mutation and response to daclatasvir and asunaprevir therapy in patients with hepatitis C virus genotype 1b International conference
Hayashi Kazuhiko, Ishigami Masatoshi, Ishizu Yoji, Kuzuya Teiji, Honda Takashi, Hirooka Yoshiki, Goto Hidemi
AASLD2015 2015.10
-
The relationship between the fever within 6 weeks after the start of sorafenib therapy and the outcome for patients with advanced hepatocellular carcinoma International conference
Kuzuya Teiji, Ishigami Masatoshi, Ishizu Yoji, Honda Takashi, Hayashi Kazuhiko, Goto Hidemi
AASLD2015 2015.10
-
コリン欠乏高脂肪食による高血糖を伴わないNASHマウスモデルにおける脂質、分岐鎖アミノ酸代謝の検討
本多 隆、石上雅敏、伊藤隆徳、安田 諭、川口 彩、加藤幸一郎、新家卓郎、今井則博、阿知波宏一、石津洋二、葛谷貞二、林 和彦、中野 功、石川哲也、片野義明、後藤秀実
第2回肝臓と糖尿病代謝研究会 2015.5.23
-
高齢者C型肝炎におけるDaclatasvir・Asunaprevir併用療法の治療早期の効果
本多 隆、石上雅敏、新家卓郎、今井則博、阿知波宏一、荒川恭宏、山田恵一、中野 聡、石津洋二、葛谷貞二、林 和彦、中野 功、石川哲也、片野義明、後藤秀実
第51回日本肝臓学会総会 2015.5.21
-
B型慢性肝炎におけるcoreI97変異がその後の経過に及ぼす影響
本多 隆、石上雅敏、川口 彩、加藤幸一郎、新家卓郎、今井則博、阿知波宏一、山田恵一、石津洋二、葛谷貞二、林 和彦、石川哲也、中野 功、後藤秀実
第101回日本消化器病学会総会 2015.4.23
-
The Prevalence of Naturally Occurring Resistance Mutations Against Direct Acting Antivirals in Patients With Hepatitis C Virus Genotype 1b and Response to Interferon Based Therapy International conference
Hayashi Kazuhiko, Ishigami Masatoshi, Ishizu Yoji, Kuzuya Teiji, Honda Takashi, Katano Yoshiaki, Goto Hidemi
DDW2015 2015.4
-
B型肝炎における経過予測及びHBs抗原消失に関与するウイルス遺伝子変異
本多 隆、石上雅敏、後藤秀実
第40回日本肝臓学会東部会 2014.11.27
-
Oral supplementation of BCAA alleviates hepatic steatosis and liver injury associated with NASH International conference
Takashi Honda, Masatoshi Ishigami, Fangqiong Luo, Yoji Ishizu, Teiji Kuzuya, Kazuhiko Hayashi, Yoshiharu Shimomura, and Hidemi Goto
AASLD2014 2014.11.9
-
Reactivation of hepatitis B virus in patients without hepatitis B surface antigen treated with immunosuppressive or chemotherapy International conference
Hayashi Kazuhiko, Ishigami Masatoshi, Ishizu Yoji, Kuzuya Teiji, Honda Takashi, Katano Yoshiaki, Hirooka Yoshiki, Goto Hidemi
APASL2014 2014.11
-
高齢者C型慢性肝炎におけるPegIFN・Ribavirin・Simeprevir3剤併用療法の治療効果
本多 隆、石上雅敏、加藤幸一郎、新家卓郎、今井則博、阿知波宏一、荒川恭宏、山田恵一、石津洋二、葛谷貞二、林 和彦、中野 功、石川哲也、後藤秀実
JDDW2014 2014.10.24
-
C型慢性肝炎難治例におけるPegIFN・Ribavirin・Telaprevir3剤併用療法の治療効果
本多 隆、石上雅敏、新家卓郎、今井則博、阿知波宏一、荒川恭宏、山田恵一、中野 聡、石津洋二、葛谷貞二、林 和彦、中野 功、石川哲也、片野義明、後藤秀実
第50 回日本肝臓学会総会 2014.5.29
-
分岐鎖アミノ酸によるNASHマウスモデルにおける肝脂肪抑制効果
本多 隆、石上雅敏、新家卓郎、今井則博、阿知波宏一、荒川恭宏、山田恵一、中野 聡、石津洋二、葛谷貞二、林 和彦、石川哲也、中野 功、後藤秀実
第100回日本消化器病学会総会 2014.4.23
-
高齢者C型慢性肝炎に対するPegIFN・Ribavirin・Telaprevir3剤併用療法の治療効果
本多 隆、片野義明、後藤秀実
JDDW2013 2013.10.10
-
The disappearance or decrease of tumor stain on contrast enhanced CT images after 2 weeks of sorafenib treatment predicts sorafenib efficacy in patients with advanced hepatocellular carcinoma International conference
Kuzuya Teiji, Ishigami Masatoshi, Hayashi Kazuhiko, Honda Takashi, Goto Hidemi
AASLD2013 2013.10
-
Prevalence of resistance mutations against NS3 protease inhibitors in patients with hepatitis C virus genotype 1b and response to telaprevir plus pegylated-interferon-alpha 2b and ribavirin combination therapy International conference
Hayashi Kazuhiko, Katano Yoshiaki, Honda Takashi, Kuzuya Teiji, Ishizu Yoji, Ishigami Masatoshi, Goto Hidemi
AASLD2013 2013.10
-
HBe抗体陽性B型慢性肝炎における経過予測に必要なウイルス遺伝子変異の検討
本多 隆、片野義明、後藤秀実
第49回日本肝臓学会総会 2013.6.7
-
Analysis of Late Onset (>= 3 Postoperative Months) Liver Dysfunction after Liver Transplantation. International conference
Ishigami Masatoshi, Ishizu Yoji, Onishi Yasuharu, Kamei Hideya, Kuzuya Teiji, Honda Takashi, Hayashi Kazuhiko, Katano Yoshiaki, Ogura Yasuhiro, Goto Hidemi
ILTS2013 2013.6
-
Effect of combination therapy peginterferon alfa-2b and ribavirin on prevention of hepatocellular carcinoma in patients with chronic hepatitis C and normal aminotransferase levels International conference
Takashi Honda, Yoshiaki Katano, Satoshi Nakano, Yoji Ishizu, Teiji Kuzuya T, Kazuhiko Hayashi, Masatoshi Ishigami, Hidemi Goto
DDW2013 2013.5.18
-
Real-Time Tissue Elastography for the Assessment of Liver Fibrosis in Patients With Chronic Hepatitis C and Correlation With Response to Pegylated-Interferon-Alpha 2B and Ribavirin Combination Therapy International conference
Hayashi Kazuhiko, Katano Yoshiaki, Ishizu Yoji, Kuzuya Teiji, Honda Takashi, Ishigami Masatoshi, Goto Hidemi
DDW2013 2013.5
-
C型慢性肝炎難治例におけるペグインターフェロン・リバビリン併用療法の治療効果と発癌抑制効果
本多 隆、片野義明、後藤秀実
第99回日本消化器病学会総会 2013.3.21
-
Reactivation of HBV by anti-tumor necrosis factor-alpha therapy in a HBs antigen-negative patient with inflammatory bowel disease International conference
Hayashi Kazuhiko, Katano Yoshiaki, Kuzuya Teiji, Honda Takashi, Ishigami Masatoshi, Itoh Akihiro, Omiya Naoki, Hirooka Yoshiki, Ando Takafumi, Goto Hidemi
APASL2012 2012.12
-
Effect of combination therapy peginterferon alfa-2b and ribavirin on prevention of hepatocellular carcinoma in advanced chronic hepatitis C International conference
Honda T, Katano Y, Kuzuya T, Hayashi K, Ishigami M, Nakano I, Toyoda H, Kumada T, Yoshioka K, Goto H
AASLD2012 2012.11.13
-
高齢者C型慢性肝炎におけるペグインターフェロン/リバビリン併用療法の治療効果と発癌抑制効果
本多 隆、片野義明、後藤秀実
第16回日本肝臓学会大会 2012.10.10
-
C型肝炎線維化進展例におけるペグインターフェロン/リバビリン併用療法の発癌抑制効果
本多 隆、片野義明、中野 聡、増田寛子、及部祐加子、石津洋二、葛谷貞二、舘 佳彦、林 和彦、石上雅敏、中野 功、石川哲也、後藤秀実
第48回日本肝臓学会総会 2012.6.8
-
A Case of HBeAg Serocoversion with Emerged Mutation of rt M 204 I/V in the Patients with Hepatitis B and HIV International conference
Honda T, Katano Y, Kuzuya T, Tachi Y, Hayashi K, Ishigami M, Nakano I, Goto H
APASL2012 2012.2.17
-
HIV、HBV重複感染例でHBVに対するラミブジン耐性株の出現後HBe抗体陽性が持続し肝炎が沈静化した1例
本多 隆, 片野義明, 中野 聡, 増田寛子, 及部祐加子, 石津洋二, 葛谷貞二, 舘 佳彦, 林 和彦, 石上雅敏, 中野 功, 石川哲也, 後藤秀実
第39回日本肝臓学会西部会 2011.12.10
-
Efficacy of Combination Therapy Peginterferon Alfa-2b and Rebavirin on Prevention of Hepatocellular Carcinoma in order Patients with Chronic Hepatitis C. International conference
Honda T, Katano Y, Kuzuya T, Tachi Y, Hayashi K, Ishigami M, Nakano I, Goto H
AASLD2011 2011.11.6
-
CLINICAL SIGNIFICANCE OF SERUM HEPATITIS B CORE RELATED ANTIGEN (HBCRAG) IN CHRONIC HBV-INFECTED PATIENTS International conference
Ishigami Masatoshi, Katano Yoshiaki, Hayashi Kazuhiko, Honda Takashi, Tachi Yoshihiko, Nakano Isao, Goto Hidemi
ILTS2010 2011.10
-
ASSOCIATION BETWEEN A SINGLE-NUCLEOTIDE POLYMORPHISM OF INTERLEUKIN 28B AND MUTATIONS IN THE NS5A REGION OF HEPATITIS C VIRUS GENOTYPE 2 WITH RESPONSE TO PEGYLATED-INTERFERON-ALPHA 2B AND RIBAVIRIN COMBINATION THERAPY International conference
Hayashi Kazuhiko, Katano Yoshiaki, Honda Takashi, Ishigami Masatoshi, Goto Hidemi, Toyoda Hidenori, Kumada Takashi
AASLD2011 2011.10
-
THE SUBSTITUTIONS IN AMINO ACID 70 IN THE HEPATITIS C VIRUS GENOTYPE 1B CORE REGION CORRELATE WITH LIVER STEATOSIS AND INSULIN RESISTANCE IN NON-OBESE PATIENTS WITH CHRONIC HEPATITIS C International conference
Tachi Yoshihiko, Ishigami Masatoshi, Hayashi Kazuhiko, Honda Takashi, Katano Yoshiaki, Kuzuya Teiji, Goto Hidemi
AASLD2011 2011.10
-
高齢者C型慢性肝炎におけるペグインターフェロン/リバビリン併用療法の発癌抑制効果
本多隆, 片野義明, 中野聡, 増田寛子, 及部祐加子, 小野幸矢, 石津洋二, 土居崎正雄, 葛谷貞二, 舘佳彦, 林和彦, 石上雅敏, 中野功, 石川哲也, 後藤秀実
DDW-Japan2011(消化器病） 2011.9
-
ペグインターフェロン、リバビリン併用療法における凝固因子の検討
本多 隆、片野義明、増田寛子、及部祐加子、小野幸矢、石津洋二、清水潤一、土居崎正雄、舘 佳彦、林 和彦、石上雅敏、中野 功、石川哲也、後藤秀実
第47回日本肝臓学会総会 2011.6.3
-
Additional Effect of Ribavirn During Peginterferon and Ribavirin Combination Therapy in Coagulation Factor International conference
Honda T,Katano Y, Hayashi K, Ishigami M, Itoh A, Hirooka Y, Goto H.
DDW2011 2011.5.8
-
高齢者C型慢性肝炎に対するペグインターフェロン/リバビリン併用療法の効果
本多 隆、片野義明、後藤秀実
日本消化器病学会東海支部第113回例会 2010.11.27
-
ASSOCIATION BETWEEN A SINGLE-NUCLEOTIDE POLYMORPHISM OF INTERLEUKIN 28B AND MUTATIONS IN THE CORE AND NS5A REGION OF HEPATITIS C VIRUS GENOTYPE 1B WITH RESPONSE TO PEGYLATED-INTERFERON-ALPHA 2B AND RIBAVIRIN COMBINATION THERAPY International conference
Hayashi Kazuhiko, Katano Yoshiaki, Honda Takashi, Ishigami Masatoshi, Nakano Isao, Goto Hidemi
AASLD2010 2010.10
-
THE ROLE OF SUBSTITUTIONS IN THE CORE AND NS5A REGION OF HEPATITIS C VIRUS GENOTYPE 1B ON RESPONSIVENESS TO PEGYLATED INTERFERON AND RIBAVIRIN COMBINATION THERAPY International conference
Katano Y., Ishigami M., Nakano I., Hayashi K., Honda T., Goto H.
EASL2009 2009
-
SHORT DURATION THERAPY OF PEGYLATED INTERFERON ALFA-2B PLUS RIBAVIRIN FOR HCV GENOTYPE 2 PATIENTS International conference
Katano Yoshiaki, Ishigami Mosatashi, Nakano Isao, Hayashi Kazuhiko, Honda Takashi, Goto Hidemi
AASLD2008 2008.10
-
Dramatic decrease in bleeding events in hemophilia A patient with inhibitor during and after receiving anti-HCV treatment with ribavirin International conference
Yamamoto K., Honda T., Toyoda H., Matsushita T., Goto H., Takamatsu J.
ILTS2008 2008.7
-
ASSESSMENT OF RELATIONSHIP BETWEEN SPLEEN VOLUME AND PLATELET COUNT AFTER LIVING DONOR LIVER TRANSPLANTATION IN JAPANESE ADULT PATIENTS International conference
Ishizu Yoji, Ishigami Masatoshi, Nishino Masamichi, Honda Takashi, Hayashi Kazuhiko, Kamei Hideya, Nakamura Taro, Katano Yoshiaki, Kiuchi Tetsuya
ILTS2008 2008.7
-
Genotype2型C型慢性肝炎に対するPegIFNα-2b/Ribavirin併用療法（短期投与の検討）
第44回日本肝臓学会総会 2008.6.6
-
高齢者C型慢性肝炎におけるペグインターフェロン・リバビリン併用療法の効果
第94回日本消化器病学会総会 2008.5.9
-
Efficacy of ribavirin plus pedinterferon-alfa in elderly patients with chronic hepatitis C International conference
Honda T, Katano Y, Doizaki K, , Hayashi K, Ishigami M, Nakano I, Urano F, Yoshioka K, Toyoda H, Kumada T, Goto H
EASL2008 2008.4.24
-
凝固障害患者（主に血友病）におけるC型慢性肝炎に対するペグインターフェロンとリバビリン併用療法の効果
第37回日本肝臓学会西部会 2007.12.8
-
C型慢性肝炎に対するペグインターフェロン・ リバビリン併用療法無効例の特徴
2007.10.18
-
Combination therapy with pegylated interferon ALFA-2B and ribavirin for patients with chronic hepatitis C and normal aminotransferase levels International conference
Kotano Yoshiaki, Ishigami Mosatoshi, Nakano Isao, Hayashi Kozuhiko, Honda Takashi, Goto Hidemi
AASLD2007 2007.10
-
Genotype2型C型慢性肝炎に対するPegIFNα-2b/Ribavirin併用療法（少量投与の検討）
本多 隆、片野 義明、中野 功、石上 雅敏、林 和彦、竹田 泰史、森井 正哉、西野 正路、後藤 新太郎、舘 佳彦、葛谷 貞二、岩田 浩史、土居崎 正雄、後藤 秀実
第43回日本肝臓学会総会 2007.5.31
-
高齢者C型肝炎に対するペグインターフェロン・リバビリン併用療法
本多隆、片野義明、後藤秀実
第93回日本消化器病学会総会 2007.4.19
-
Efficacy of ribavirin plus interferon-alfa in elderly patients with chronic hepatitis C International conference
Honda T, Katano Y, Urano F, Hayashi K, Ishigami M, Nakano I, Yoshioka Y, Toyoda H, Kumada T, Goto H
EASL2007 2007.4.13
-
Characteristic of the nonresponder to pegylated-interferon and ribavirin combination therapy in patients with hepatitis C virus genotype 1 infection International conference
Honda T, Katano Y, Nakano I, Ishigami M, Hayashi K, Yoshioka K, Kumada T, Toyoda H, Goto H
APASL2007 2007.3.29
-
ADDITIONAL EFFECT OF RIBAVIRIN DURING PEGINTERFERON AND RIBAVIRIN COMBINATION THERAPY International conference
Honda T, Katano Y, Toyoda H, Kumada T, Hayashi K, Ishigami M, Nakano I, Yamamoto K, Takamatsu J and Goto H
AASLD2007 Single Topic Conference 2007.3.2
-
Efficacy of ribavirin plus interferon-alfa in elderly patients with chronic hepatitis C International conference
Honda T., Katano Y., Urano F., Hayashi K., Ishigami M., Nakano I., Yoshioka K., Toyoda H., Kumada T., Goto H.
EASL2007 2007
-
C型慢性肝炎に対するペグインターフェロン・ リバビリン併用療法（無効例の検討）
DDW-Japan2006(肝臓） 2006.10
-
ALT正常C型慢性肝炎に対するペグインターフェロン・リバビリン併用療法
本多隆、片野義明、後藤秀実
第41回日本肝臓学会総会 2006.5
-
Comparison of clinical and virological feature between genotype A and genotype C among patients with acute hepatitis B in Japan International conference
Takeda Yasushi, Takano Yoshiaki, Hayashi Kazuhiko, Ishigami Masatoshi, Honda Takashi, Goto Hidemi
APASL2006 2006.3
-
ALT正常C型慢性肝炎に対するインターフェロン・リバビリン併用療法のウイルス学的効果
第36回日本肝臓学会西部会 2005.11.25
-
Anti-HCV agent, ribavirin, decreases events of bleeding in hemophilia patients, possibly by elevating the clotting activity of factor VII. International conference
Yamamoto K, Honda T, Suzuki S, Toyoda H, Matsushita T, Kojima T, Goto H, Takamatsu J
ASH2005 2005.11.16
-
高齢者C型慢性肝炎におけるインターフェロンとリバビリン併用療法の効果
本多隆、片野義明、後藤秀実
Digestive Disease Week-Japan 2005 2005.10
-
HBV genotype distribution differs in acute hepatitis from chronic hepatitis in Japan International conference
Takeda Y, Katano Y, Hayashi K, Honda T, Goto H
AMERICAN JOURNAL OF GASTROENTEROLOGY 2005.9
-
C型慢性肝炎に対するインターフェロンリバビリン併用療法におけるNon-responderの検討
本多隆、片野義明、石黒裕規、仲島さより、村山睦、竹田泰史、小田切英樹、西野正路、山田晋太郎、佐々木論実彦、横崎正一、石上雅敏、長野健一、中野功、矢野元義、後藤秀実
第41回日本肝臓学会総会 2005.6
-
JISscore,CLIPsore及びTokyo scoreを用いた肝細胞癌治療法別の予後
第41回日本肝臓学会総会 2005.6
-
JISscore及びCLIPscoreを用いた肝細胞癌治療法別の予後
本多隆、片野義明、後藤秀実
日本消化器病学会東海支部第101回例会 2005.1
-
C型慢性肝炎に対するインターフェロン・リバビリン併用療法後のインターフェロン単独療法追加による著効率の向上
第8回日本肝臓学会大会 2004.10
-
C型慢性肝炎に対するインターフェロン・リバビリン併用療法におけるウイルス学、生化学的効果の検討
2004.6
-
高齢者C型慢性肝炎におけるインターフェロンとリバビリン併用療法の検討
本多隆、片野義明、後藤秀実
第90回日本消化器病学会総会 2004.4
-
血友病患者におけるoccult HBV infectionの頻度とその臨床的意義
第7回日本肝臓学会大会 2003.10.16
-
急性肝不全および肝硬変での分岐鎖アミノ酸代謝の違い
第39回日本肝臓学会総会 2003.5.22
-
Differences in branched-chain amino acid catabolism between acute liver failure and liver cirrhosis in rats International conference
Honda T., Shimomura. Y., Fukuda Y. Nakano I., Katano Y. Murakami T., Nagasaki M.
Experimental Biology 2003 2003.4.13
-
Association of mutations in two PKR binding domains of hepatitis C virus genotype 3a and viral loads International conference
Fukuda Y, Katano Y, Toyoda H, Yokozaki S, Hayashi K, Naito T, Shimizu H, Honda T, Otakiri H, Takeda Y, Nakashima S, Ishiguro H, Nakano I
EASL2003 2003.4
-
Responses to retraining of glucose uptake in rat skeletal muscle International conference
Nagasiaki M, Shimomura Y, Bajotto G, Honda T, Oshida Y, Sato Y
FASEB JOURNAL 2003.3.17
-
Comparison between iron reduction therapy versus vitamin E treatment of chronic hepatitis C who previously failed interferon therapy International conference
Hayashi K, Fukuda Y, Nakano I, Katano Y, Toyoda H, Yokozaki S, Naito T, Shimizu H, Shimizu Y, Honda T, Otakiri H
APASL2002 2002
-
Immunologic dynamics in a patient with tandem acute infection by HCV and HBV. International conference
Fukuda Y, Nakano I, Katano Y, Nagano K, Yokozaki S, Hayashi K, Shimizu H, Shimizu F, Naito T, Honda T, Shizu Y, Hayakawa T
EASL2001 2001.10